An Extension of the Continual Reassessment Method Using Decision Theory
The primary goal of a phase I trial is to find the maximally tolerated dose (MTD) of a treatment. The MTD is usually defined in terms of a tolerable probability, q*, of toxicity. Our objective is to find the highest dose with toxicity risk that does not exceed q*, a criterion that is often desired i...
Saved in:
Main Authors: | Leung, Denis H. Y., Wang, Y. G. |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2002
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/soe_research/414 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
Similar Items
-
Reassessing the determinants of international stock market correlation
by: Pandej Chintrakarn, et al.
Published: (2018) -
Bound estimator of HIV prevalence: Application to Malawi
by: FUJII, Tomoki, et al.
Published: (2014) -
An Optimal Sequential Design for Screening Trials
by: Wang, Y. G., et al.
Published: (1998) -
An Improved up-and-Down Design for Phase I Trials
by: Leung, Denis H. Y., et al.
Published: (2001) -
A Clinical Evaluation of the Hemocue Haemoglobinometer Using Capillary, Venous and Arterial Samples
by: Chen, P. P., et al.
Published: (1992)